Hongxing Li

2.3k citations
76 papers · 1.5k indexed · h-index 22

Hongxing Li

72 papers receiving 1.5k citations

Peers

Hongxing Li
Comparison fields: 5 of 123
  • Immunology 295
  • Infectious Diseases 212
  • Cancer Research 169
  • Immunology and Allergy 64
  • Rheumatology 155
Replace Marc Vasse with:
Marc Vasse France
Letizia Scola Italy
Chie Kurihara Japan
Luisa Morales‐Nebreda United States
Takuro Sakagami Japan
Shunji Hasegawa Japan
Matilde Bustos Spain
Jacqueline M. Hibbert United States
Jean‐Claude Pache Switzerland
Wei Han United States
Hongxing Li relative to Marc Vasse France Marc Vasse's profile →
Citations per field
00.5×2.5×
Marc Vasse · 1×
Citations per year

Countries citing papers authored by Hongxing Li

Since Specialization
Citations

This map shows the geographic impact of Hongxing Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongxing Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongxing Li more than expected).

Fields of papers citing papers by Hongxing Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongxing Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongxing Li. The network helps show where Hongxing Li may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Hongxing Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hongxing Li Line = papers co-authored together Hongxing Li links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20243
3 20233
4 20231
5 202213
6 20217
7 202111
8 20208
9 20206
10 20203
11 201824
12 201626
13 201620
14 201615
15 20151
16
Analysis on content of total volatile alkali, total volatile acid and pH value in flue-cured tobacco leaves from Guangdong tobacco-growing areas.
20141
17 20145
18 20111
19 200415
20 200361

About Hongxing Li

Hongxing Li is a scholar working on Cancer Research, Rheumatology and Epidemiology, having authored 76 papers that have together received 1.5k indexed citations. Recurring topics across this work include Congenital gastrointestinal and neural anomalies (12 papers), Cancer-related molecular mechanisms research (6 papers), interferon and immune responses (5 papers), Circular RNAs in diseases (4 papers), Congenital Anomalies and Fetal Surgery (3 papers), Total Knee Arthroplasty Outcomes (3 papers), Herpesvirus Infections and Treatments (3 papers) and Cytokine Signaling Pathways and Interactions (3 papers). The work is most often cited by research in Immunology (295 citations), Infectious Diseases (212 citations) and Cancer Research (169 citations). Hongxing Li has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Xinzhan Mao, Xin Su, Yi Shi, Qian He, Weibing Tang, Wei Zhou, Yankai Xia, Jin‐Kui Yang, Lloyd Mayer and Daniel M. George. Their work appears in journals such as Journal of Craniofacial Surgery, Journal of Hazardous Materials, Gastroenterology, Tumor Biology and Frontiers in Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026